Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites

BASILDON, England:   Catumaxomab Received a Positive Opinion From the EMA’s Committee for Medicinal Products for Human Use (CHMP) at

READ MORE

Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea

TOKYO, Japan & Seattle, Cambridge, Mass., United States:   World’s first approved allogeneic cell therapy for corneal endothelial disease Prof. Shigeru

READ MORE

Scientists, civil society members write open letter to Bharat Biotech and ICMR over prosecution of researchers

The Covid-19 vaccine, Covaxin, developed by Bharat Biotech. File photograph An open letter written to vaccine manufacturer Bharat Biotech International Ltd and to the Indian

READ MORE

Notice to attend the Extraordinary General Meeting in ExpreS2ion Biotech Holding AB (publ)

N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies between the

READ MORE

Global Bio-India 2024 successfully concludes with India Showcasing Its Biotech Prowess

Global Bio-India 2024 successfully concludes with India Showcasing Its Biotech Prowess Source link

READ MORE

Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services

Boston, United States:   Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been

READ MORE